肺炎球菌ワクチンの世界市場

Future Market Insightsが発行した調査報告書(FUMI809261)
◆英語タイトル:Pneumococcal Vaccines Market: North America to Register Fastest Growth During the Forecast Period: Global Industry Analysis 2013 - 2017 and Opportunity Assessment 2018 - 2028
◆商品コード:FUMI809261
◆発行会社(リサーチ会社):Future Market Insights
◆発行日:2018年7月19日
◆ページ数:187
◆レポート形式:英語 / PDF
◆納品方法:Eメール
◆調査対象地域:グローバル
◆産業分野:医療・医薬品・医療機器
◆販売価格オプション(消費税別)
Individual Price(1名様閲覧用)USD5,000 ⇒換算¥565,000見積依頼/購入/質問フォーム
Corporate Price(同一法人内共有可)USD7,500 ⇒換算¥847,500見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はFuture Market Insights社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。Future Market Insights社の概要及び新刊レポートはこちらでご確認いただけます。

※本調査レポートでは、肺炎球菌ワクチンの世界市場について調査・分析し、以下の構成でお届けいたします。
・肺炎球菌ワクチンの世界市場の世界市場概観
・肺炎球菌ワクチンの世界市場の世界市場規模
・肺炎球菌ワクチンの世界市場の世界市場予測
・肺炎球菌ワクチンの世界市場の世界市場:地域別市場分析
・肺炎球菌ワクチンの世界市場のアメリカ市場規模
・肺炎球菌ワクチンの世界市場のヨーロッパ市場規模
・肺炎球菌ワクチンの世界市場のアジア市場規模
・肺炎球菌ワクチンの世界市場の世界市場:セグメント別市場分析
・肺炎球菌ワクチンの世界市場の世界市場:競争状況
・肺炎球菌ワクチンの世界市場の世界市場:市場動向
・肺炎球菌ワクチンの世界市場の世界市場:関連企業分析
【レポートの概要】

Future Market Insights (FMI) offers a 10-year forecast on the global pneumococcal vaccines market. The primary objective of the report is to offer updates and information related to opportunities in the global pneumococcal vaccines market.

Report Description

In terms of revenue, the global pneumococcal vaccines market is expected to register a CAGR of 9.1% during the forecast period of 2018–2028. The primary objective of the report is to offer insights on the market dynamics that can influence the growth of the global pneumococcal vaccines market over the forecast period. Insights on the key trends, drivers, restraints, value forecasts and opportunities for companies operating in the global pneumococcal vaccines market are presented in the report.

The global demand for pneumococcal vaccines is increasing as a result of the large burden of pneumonia-related child mortality rate. Pneumonia is the leading cause of child deaths. 16% of all deaths under age 5 are due to pneumonia. The governments across the globe are focusing on reducing the mortality rate with the help of pneumococcal immunization, which is expected to fuel the growth of the pneumococcal vaccines market. Besides, the support from Gavi to low-income countries for pneumococcal immunization is expected to boost the growth of the pneumococcal vaccines market. Availability of cost-effective vaccines in developing countries as well as favourable reimbursement policies for pneumococcal conjugate and polysaccharide vaccine are expected to spur the demand for pneumococcal vaccines.

Research & development activities for the development of new pneumococcal vaccines, balanced supply and demand, government and private funding for pneumococcal vaccines are expected to boost the demand for pneumococcal vaccines over the forecast period. Manufacturers are focusing on mergers and collaborations for the development of new vaccines, whereas increasing pharmacy-based pneumococcal immunization is expected to create huge opportunities for growth of the pneumococcal vaccines market.

The revenue of the pneumococcal vaccines market in North America is expected to grow at the high rate. To understand and assess opportunities in this market, the report offers the market forecast on the basis of product type and distribution channel. The report provides analysis of the global pneumococcal vaccines market in terms of market value (US$ Mn).

The report begins with the market definition, followed by definitions of the different pneumococcal vaccines types. The market dynamics section includes FMI’s analysis on key trends, drivers, restraints, opportunities and macro-economic factors influencing the growth of the global pneumococcal vaccines market. Opportunity analysis provided in the section allows clients to better equip with crystal clear decision-making insights

The subsequent section of the report provides analysis of the market on the basis of regions and presents forecast in terms of value for the next 10 years. The regions covered in the report include:

North America

U.S.

Canada

Latin America

Brazil

Mexico

Rest of Latin America

Western Europe

Germany

Italy

France

Spain

U.K.

Rest of Western Europe

Eastern Europe

Russia

Poland

Rest of Eastern Europe

Asia Pacific Excluding Japan

India

China

ASEAN

Australia & New Zealand

Rest of APEJ

Japan

Middle East & Africa (MEA)

GCC Countries

South Africa

Rest of MEA

The next section provides competitive edge of the global pneumococcal vaccines market. This section is primarily designed to provide clients with an objective and detailed comparative assessment of the key providers specific to a market segment in the pneumococcal vaccines market. The competition landscape section provides dashboard view of the activities of major players in the global pneumococcal vaccines market. The company profiles section provides information on the key offerings of each player in the global pneumococcal vaccines market, their direct & indirect presence, revenue, key developments and strategies and SWOT analysis. The key players included in this report are Pfizer Inc., Sanofi S.A., GlaxoSmithKline Plc., Merck & Co., Inc.

The next section analyses the market on the basis of product type and presents the forecast in terms of value (US$ Mn) for the next 10 years. The product types covered in the report include:

Pneumococcal Polysaccharide Vaccines

Pneumococcal Conjugate Vaccines

The next section analyses the market on the basis of the distribution channel and presents forecast in terms of value (US$ Mn) for the next 10 years. The distribution channels covered in the report include:

Pharmacies

Community Clinics

Public Health Agencies

Others

In addition, we have considered Year-on-Year (Y-o-Y) growth to understand the predictability of the market and identify growth opportunities for companies operating in the global pneumococcal vaccines market.

Another key feature of this report is the analysis of the key segments in terms of absolute dollar opportunity. This is usually overlooked while forecasting the market. However, absolute dollar opportunity is critical for assessing the level of opportunity that a provider can look to achieve, as well as to identify potential resources from a sales and delivery perspective for services offered by pneumococcal vaccines market. To understand the key segments in terms of their growth and performance in the global pneumococcal vaccines market, Future Market Insights has developed a market attractiveness index. The resulting index will help providers to identify the existing market opportunities.

【レポートの目次】

1. Executive Summary

1.1. Market Overview

1.2. Market Analysis

1.3. FMI Analysis and Recommendations

1.4. Wheel of Fortune

2. Market Introduction

2.1. Market Taxonomy

2.2. Market Definition

3. Pneumococcal Vaccines Market Opportunity Analysis

3.1. Macro-Economic Factors

3.2. Opportunity Analysis

4. Market Background

4.1. Market Dynamics

4.1.1. Drivers

4.1.2. Restraints

4.1.3. Key Trends

5. Key Inclusions

5.1. Disease Epidemiology

5.2. Reimbursement Scenario

5.3. Pipeline Assessment

6. Respiratory Syncytial Virus (RSV) Vaccines Market, Pipeline Assessment

7. North America Pneumococcal Vaccines Market Analysis 2013–2017 and Forecast 2018–2028

7.1. Introduction

7.2. Historical Market Size (US$ Mn) Analysis By Country, 2013–2017

7.2.1. U.S.

7.2.2. Canada

7.3. Market Size (US$ Mn) Forecast By Country, 2018–2028

7.4. Historical Market Size (US$ Mn) Trend Analysis By Product Type, 2013–2017

7.4.1. Pneumococcal Conjugate Vaccines

7.4.2. Pneumococcal Polysaccharide Vaccines

7.5. Market Size (US$ Mn) Forecast By Product Type, 2018–2028

7.6. Historical Market Size (US$ Mn) Trend Analysis By Distribution Channel, 2013–2017

7.6.1. Pharmacies

7.6.2. Community Clinics

7.6.3. Public Health Agencies

7.6.4. Others

7.7. Market Size (US$ Mn) Forecast By Distribution Channel, 2018–2028

7.8. Market Attractiveness Analysis

7.8.1. By Country

7.8.2. By Product

7.8.3. By Distribution Channel

7.9. Key Market Participants – Intensity Mapping

8. Latin America Pneumococcal Vaccines Market Analysis 2013–2017 and Forecast 2018–2028

8.1. Introduction

8.2. Historical Market Size (US$ Mn) By Country, 2013–2017

8.2.1. Brazil

8.2.2. Mexico

8.2.3. Rest of Latin America

8.3. Market Size (US$ Mn) Forecast By Country, 2018–2028

8.4. Historical Market Size (US$ Mn) Trend Analysis By Product Type, 2013–2017

8.4.1. Pneumococcal Conjugate Vaccines

8.4.2. Pneumococcal Polysaccharide Vaccines

8.5. Market Size (US$ Mn) Forecast By Product Type, 2018–2028

8.6. Historical Market Size (US$ Mn) Trend Analysis By Distribution Channel, 2013–2017

8.6.1. Pharmacies

8.6.2. Community Clinics

8.6.3. Public Health Agencies

8.6.4. Others

8.7. Market Size (US$ Mn) Forecast By Distribution Channel, 2018–2028

8.8. Market Attractiveness Analysis

8.8.1. By Country

8.8.2. By Product

8.8.3. By Distribution Channel

8.9. Key Market Participants – Intensity Mapping

9. Western Europe Pneumococcal Vaccines Market Analysis 2013–2017 and Forecast 2018–2028

9.1. Introduction

9.2. Historical Market Size (US$ Mn) By Country, 2013–2017

9.2.1. Germany

9.2.2. France

9.2.3. U.K.

9.2.4. Spain

9.2.5. Italy

9.2.6. Rest of Western Europe

9.3. Market Size (US$ Mn) Forecast By Country, 2018–2028

9.4. Historical Market Size (US$ Mn) Trend Analysis By Product Type, 2013–2017

9.4.1. Pneumococcal Conjugate Vaccines

9.4.2. Pneumococcal Polysaccharide Vaccines

9.5. Market Size (US$ Mn) Forecast By Product Type, 2018–2028

9.6. Historical Market Size (US$ Mn) Trend Analysis By Distribution Channel, 2013–2017

9.6.1. Pharmacies

9.6.2. Community Clinics

9.6.3. Public Health Agencies

9.6.4. Others

9.7. Market Size (US$ Mn) Forecast By Distribution Channel, 2018–2028

9.8. Market Attractiveness Analysis

9.8.1. By Country

9.8.2. By Product

9.8.3. By Distribution Channel

9.9. Key Market Participants – Intensity Mapping

10. Eastern Europe Pneumococcal Vaccines Market Analysis 2013–2017 and Forecast 2018–2028

10.1. Introduction

10.2. Historical Market Size (US$ Mn) By Country, 2013–2017

10.2.1. Russia

10.2.2. Poland

10.2.3. Rest of Eastern Europe

10.3. Market Size (US$ Mn) Forecast By Country, 2018–2028

10.4. Historical Market Size (US$ Mn) Trend Analysis By Product Type, 2013–2017

10.4.1. Pneumococcal Conjugate Vaccines

10.4.2. Pneumococcal Polysaccharide Vaccines

10.5. Market Size (US$ Mn) Forecast By Product Type, 2018–2028

10.6. Historical Market Size (US$ Mn) Trend Analysis By Distribution Channel, 2013–2017

10.6.1. Pharmacies

10.6.2. Community Clinics

10.6.3. Public Health Agencies

10.6.4. Others

10.7. Market Size (US$ Mn) Forecast By Distribution Channel, 2018–2028

10.8. Market Attractiveness Analysis

10.8.1. By Country

10.8.2. By Product

10.8.3. By Distribution Channel

10.9. Key Market Participants – Intensity Mapping

11. Asia Pacific excluding Japan and China (APEJ) Pneumococcal Vaccines Market Analysis 2013–2017 and Forecast 2018–2028

11.1. Introduction

11.2. Historical Market Size (US$ Mn) By Country, 2013–2017

11.2.1. India

11.2.2. China

11.2.3. Australia and New Zealand

11.2.4. ASEAN

11.2.5. Rest of APEJ

11.3. Market Size (US$ Mn) Forecast By Country, 2018–2028

11.4. Historical Market Size (US$ Mn) Trend Analysis By Product Type, 2013–2017

11.4.1. Pneumococcal Conjugate Vaccines

11.4.2. Pneumococcal Polysaccharide Vaccines

11.5. Market Size (US$ Mn) Forecast By Product Type, 2018–2028

11.6. Historical Market Size (US$ Mn) Trend Analysis By Distribution Channel, 2013–2017

11.6.1. Pharmacies

11.6.2. Community Clinics

11.6.3. Public Health Agencies

11.6.4. Others

11.7. Market Size (US$ Mn) Forecast By Distribution Channel, 2018–2028

11.8. Market Attractiveness Analysis

11.8.1. By Country

11.8.2. By Product

11.8.3. By Distribution Channel

11.9. Key Market Participants – Intensity Mapping

12. Japan Pneumococcal Vaccines Market Analysis 2013–2017 and Forecast 2018–2028

12.1. Introduction

12.2. Historical Market Size (US$ Mn) Trend Analysis By Product Type, 2013–2017

12.2.1. Pneumococcal Conjugate Vaccines

12.2.2. Pneumococcal Polysaccharide Vaccines

12.3. Market Size (US$ Mn) Forecast By Product Type, 2018–2028

12.4. Historical Market Size (US$ Mn) Trend Analysis By Distribution Channel, 2013–2017

12.4.1. Pharmacies

12.4.2. Community Clinics

12.4.3. Public Health Agencies

12.4.4. Others

12.5. Market Size (US$ Mn) Forecast By Distribution Channel, 2018–2028

12.6. Market Attractiveness Analysis

12.6.1. By Product

12.6.2. By Distribution Channel

12.7. Key Market Participants – Intensity Mapping

13. MEA Pneumococcal Vaccines Market Analysis 2013–2017 and Forecast 2018–2028

13.1. Introduction

13.2. Market Size (US$ Mn) Forecast By Country, 2018–2028

13.3. Historical Market Size (US$ Mn) Trend Analysis By Product Type, 2013–2017

13.3.1. Pneumococcal Conjugate Vaccines

13.3.2. Pneumococcal Polysaccharide Vaccines

13.4. Market Size (US$ Mn) Forecast By Product Type, 2018–2028

13.5. Historical Market Size (US$ Mn) Trend Analysis By Distribution Channel, 2013–2017

13.5.1. Pharmacies

13.5.2. Community Clinics

13.5.3. Public Health Agencies

13.5.4. Others

13.6. Market Size (US$ Mn) Forecast By Distribution Channel, 2018–2028

13.7. Market Attractiveness Analysis

13.7.1. By Country

13.7.2. By Product

13.7.3. By Distribution Channel

13.8. Key Market Participants – Intensity Mapping

14. Forecast Factors: Relevance and Impact

15. Drivers and Restraints: Impact Analysis

16. Macroeconomic Assumptions

17. Market Share Analysis

18. Competition Analysis

18.1. Competition Dashboard

18.2. Company Deep Dive

18.2.1. Pfizer Inc.

18.2.1.1. Overview

18.2.1.2. Product Portfolio

18.2.1.3. Production Footprint

18.2.1.4. Sales Footprint

18.2.1.5. Strategy

18.2.1.5.1. Marketing Strategy

18.2.1.5.2. Product Strategy

18.2.1.5.3. Channel Strategy

18.2.2. Merck & Co., Inc.

18.2.2.1. Overview

18.2.2.2. Product Portfolio

18.2.2.3. Production Footprint

18.2.2.4. Sales Footprint

18.2.2.5. Strategy

18.2.2.5.1. Marketing Strategy

18.2.2.5.2. Product Strategy

18.2.2.5.3. Channel Strategy

18.2.3. GlaxoSmithKline plc.

18.2.3.1. Overview

18.2.3.2. Product Portfolio

18.2.3.3. Production Footprint

18.2.3.4. Sales Footprint

18.2.3.5. Strategy

18.2.3.5.1. Marketing Strategy

18.2.3.5.2. Product Strategy

18.2.3.5.3. Channel Strategy

18.2.4. Sanofi SA

18.2.4.1. Overview

18.2.4.2. Product Portfolio

18.2.4.3. Production Footprint

18.2.4.4. Sales Footprint

18.2.4.5. Strategy

18.2.4.5.1. Marketing Strategy

18.2.4.5.2. Product Strategy

18.2.4.5.3. Channel Strategy

19. Global Pneumococcal Vaccines Market Analysis 2013–2017 and Forecast 2018–2028, By Region

19.1. Introduction / Key Findings

19.2. Historical Market Size (US$ Mn) Trend Analysis By Region, 2013–2017

19.2.1. North America

19.2.2. Western Europe

19.2.3. Eastern Europe

19.2.4. Latin America

19.2.5. Asia Pacific excluding Japan

19.2.6. Japan

19.2.7. Middle East and Africa

19.3. Market Size (US$ Mn) Forecast By Region, 2018–2028

19.4. Market Attractiveness Analysis By Region

20. Global Pneumococcal Vaccines Market Analysis 2013–2017 and Forecast 2018–2028, By Product

20.1. Introduction

20.2. Historical Market Size (US$ Mn) Trend Analysis By Product Type, 2013–2017

20.2.1. Pneumococcal Conjugate Vaccines

20.2.2. Pneumococcal Polysaccharide Vaccines

20.3. Market Size (US$ Mn) Forecast By Product Type, 2018–2028

20.4. Market Attractiveness Analysis By Product Type

21. Global Pneumococcal Vaccines Market Analysis 2013–2017 and Forecast 2018–2028, By Distribution Channel

21.1. Introduction

21.2. Historical Market Size (US$ Mn) Trend Analysis By Distribution Channel, 2013–2017

21.2.1. Pharmacies

21.2.2. Community Clinics

21.2.3. Public Health Agencies

21.2.4. Others

21.3. Market Size (US$ Mn) Forecast By Distribution Channel, 2018–2028

21.4. Market Attractiveness Analysis By Distribution Channel

22. Global Pneumococcal Vaccines Market Analysis 2013–2017 and Forecast 2018–2028

22.1. Market Value Share Analysis

22.1.1. By Country

22.1.2. By Product

22.1.3. By Distribution Channel

22.2. Y-o-Y Growth Analysis

22.2.1. By Country

22.2.2. By Product

22.2.3. By Distribution Channel

22.3. Absolute $ Opportunity

23. Assumptions and Acronyms

24. Research Methodology



【レポートのキーワード】

肺炎球菌ワクチン

【免責事項】
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ 肺炎球菌ワクチンの世界市場(Pneumococcal Vaccines Market: North America to Register Fastest Growth During the Forecast Period: Global Industry Analysis 2013 - 2017 and Opportunity Assessment 2018 - 2028)]についてメールでお問い合わせはこちらでお願いします。


◆H&Iグローバルリサーチのお客様(例)◆